Gilead Sciences plans to acquire Ouro Medicines for up to about $2.18 billion and develop the assets from the deal in a ...
In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into ...
Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...
Q4 2025 Management View Richard A. Stewart, President, CEO & Executive Director, emphasized the company's transition from a clinical-stage to a commercially focused enterprise following the NDA ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Add Yahoo as a preferred source to see more of our stories on Google. South Korea–based biotech firm 3billion plans to open a 13,000-square-foot AI-driven genetic testing lab in North Austin, a ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Exact Sciences is projected to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Life sciences is struggling across the country, but some industry executives in Greater Philadelphia believe the region is well-positioned for when the headwinds relent — though it's not clear when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results